SYNCROMUNE
Syncromune™ is a privately held, clinical stage biopharmaceutical company dedicated to the development of better immunotherapies for metastatic solid tumor cancers. We are at the forefront of developing combination immunotherapies, which several thought leaders consider to be the future of cancer therapy. We are committed to bringing life-changing treatments to patients with unmet medical needs by fighting cancer in a new way. The company is currently developing Syncrovax™, a proprietary... platform technology that uses a combination approach to synchronize the timing and location of tumor antigen release with the functional activation and education of immune cells. An in situ vaccine is created from the patient’s own tumor antigens, making it a personalized treatment for each patient. The platform is designed to optimize T cells and the immune system to treat metastatic solid tumors where other therapies have failed.
SYNCROMUNE
Industry:
Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
Fort Lauderdale, Florida, United States
Country:
United States
Website Url:
http://www.syncromune.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10 M USD
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuCâ„¢ platform.
Current Employees Featured
Founder
More informations about "Syncromune"
Company and Leadership — Syncromune® Inc.
Syncromune is a privately held, clinical-stage biopharmaceutical company dedicated to the development of an in situ platform therapy optimized for metastatic solid tumor cancers that …See details»
Syncromune™ — Synchronizing the Power of …
Dec 2, 2024 Syncromuneâ„¢ is developing SYNC-Tâ„¢, a disruptive platform immunotherapy designed to optimize T cells and the immune system to attack cancer throughout the body.See details»
Syncromune - Crunchbase Company Profile & Funding
Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.See details»
Syncromune® - LinkedIn
Syncromune is a privately held, clinical-stage biopharmaceutical company dedicated to the development of an in situ platform therapy optimized for metastatic solid tumor cancers that aims to ...See details»
Syncromune - Contacts, Employees, Board Members, Advisors
Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.See details»
Press Release Distribution and Management - GlobeNewswire
Mar 6, 2024 GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.See details»
Syncromune 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Syncromune. Use the PitchBook Platform to explore the full profile.See details»
Patients — Syncromune® Inc.
Syncromune is an oncology-focused biopharmaceutical company committed to developing therapies that may improve the lives of cancer patients. Our focus centers around conducting clinical research that evaluates the safety and …See details»
Syncromune - Funding, Financials, Valuation & Investors
Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.See details»
Syncromune, Inc. Company Profile | Fort Lauderdale, FL
Find company research, competitor information, contact details & financial data for Syncromune, Inc. of Fort Lauderdale, FL. Get the latest business insights from Dun & Bradstreet.See details»
Syncromune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Syncromune, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 11 news, and 1 literature, Disease Domain:Neoplasms ...See details»
Syncromune® Inc. Expands Scientific Advisory Board with …
Oct 31, 2023 Syncromune is a privately held, clinical-stage biopharmaceutical company dedicated to the development of an in situ platform technology optimized for metastatic solid …See details»
Syncromune, a Fort Lauderdale-based biotech, raises $100M …
Dec 23, 2024 Syncromune, a Fort Lauderdale-based biotech startup on a mission to develop first in class immunotherapies for solid tumors in the oncology field, has raised a $100 million …See details»
Syncromune Appoints Zhihong Li, Ph.D., as Chief Regulatory …
2 days ago FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, March 25, 2025 (GLOBE NEWSWIRE) — Syncromune ® Inc., a clinical-stage biopharmaceutical company …See details»
Syncromune - Crunchbase
Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.See details»
Syncromune, Inc. - ASCO Annual 2024
Jun 3, 2024 Syncromune is a privately held, clinical-stage biopharmaceutical company dedicated to the development of SYNC-T, an in situ platform therapy that combines a multi …See details»
Syncromune Appoints Zhihong Li, Ph.D., as Chief Regulatory …
1 day ago FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, March 25, 2025 (GLOBE NEWSWIRE) -- Syncromune ® Inc., a clinical-stage biopharmaceutical company developing …See details»
SYNC-T Solid Tumor Treatment Platform - Syncromune® Inc.
Syncromune is currently focused on developing therapies for metastatic non-small cell lung cancer, metastatic breast cancer, and metastatic castration-resistant prostate cancer. There is …See details»
Syncromune’s Innovative Approach to Solid Tumor Immunotherapy
Sep 27, 2024 Syncromune, a privately held, clinical-stage biopharmaceutical company headquartered in Fort Lauderdale, Florida, is innovating immunotherapy for cancer treatment. …See details»
Syncromune - Updates, News, Events, Signals & Triggers
Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.See details»